HEADER ONCOPROTEIN/TRANSFERASE 23-MAY-22 8CYI TITLE CRYO-EM STRUCTURES AND COMPUTATIONAL ANALYSIS FOR ENHANCED POTENCY IN TITLE 2 MTA-SYNERGIC INHIBITION OF HUMAN PROTEIN ARGININE METHYLTRANSFERASE 5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN ARGININE N-METHYLTRANSFERASE 5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 72 KDA ICLN-BINDING PROTEIN,HISTONE-ARGININE N- COMPND 5 METHYLTRANSFERASE PRMT5,JAK-BINDING PROTEIN 1,SHK1 KINASE-BINDING COMPND 6 PROTEIN 1 HOMOLOG,SKB1HS; COMPND 7 EC: 2.1.1.320; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: METHYLOSOME PROTEIN 50; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: MEP-50,ANDROGEN RECEPTOR COFACTOR P44,WD REPEAT-CONTAINING COMPND 13 PROTEIN 77,P44/MEP50; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRMT5, HRMT1L5, IBP72, JBP1, SKB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: WDR77, MEP50, WD45, HKMT1069, NBLA10071; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PRMT5, PROTEIN ARGININE METHYL TRANSFERASE, MTA-INHIBITOR SYNERGY, KEYWDS 2 CRYO-EM STRUCTURE-BASED DRUG DESIGN, COMPUTATIONAL ANALYSIS, KEYWDS 3 CATALYTIC MECHANISM, DRUG DISCOVERY, DOCKING ANALYSIS, ONCOPROTEIN, KEYWDS 4 ONCOPROTEIN-TRANSFERASE COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR G.P.YADAV,Z.WEI,Y.XIAOZHI,L.CHENGLONG,Q.JIANG REVDAT 2 12-JUN-24 8CYI 1 REMARK REVDAT 1 12-APR-23 8CYI 0 JRNL AUTH W.ZHOU,G.P.YADAV,X.YANG,F.QIN,C.LI,Q.X.JIANG JRNL TITL CRYO-EM STRUCTURE-BASED SELECTION OF COMPUTED LIGAND POSES JRNL TITL 2 ENABLES DESIGN OF MTA-SYNERGIC PRMT5 INHIBITORS OF BETTER JRNL TITL 3 POTENCY. JRNL REF COMMUN BIOL V. 5 1054 2022 JRNL REFN ESSN 2399-3642 JRNL PMID 36192627 JRNL DOI 10.1038/S42003-022-03991-9 REMARK 2 REMARK 2 RESOLUTION. 3.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CISTEM, LEGINON, CTFFIND, ISOLDE, REMARK 3 CISTEM, CISTEM, CISTEM, CISTEM, PHENIX, REMARK 3 ISOLDE REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : OTHER REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : 68.000 REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.140 REMARK 3 NUMBER OF PARTICLES : 207392 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8CYI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1000263661. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX OF PRMT5 AND MEP50 IN REMARK 245 THE PRESENCE OF MTA AND A NOVEL REMARK 245 INHIBITOR (11-2F) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.40 REMARK 245 SAMPLE SUPPORT DETAILS : PRECLEAN PLASMA CLEANER REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 4115 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : DARK FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 MET A 4 REMARK 465 ALA A 5 REMARK 465 VAL A 6 REMARK 465 GLY A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 GLY A 11 REMARK 465 SER A 12 REMARK 465 THR B 245 REMARK 465 SER B 246 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH TYR B 36 HG1 THR B 314 1.11 REMARK 500 HG SER B 57 HE1 TRP B 59 1.19 REMARK 500 HG SER B 279 HH21 ARG B 292 1.28 REMARK 500 HG CYS B 172 H LEU B 218 1.32 REMARK 500 H GLN A 497 H PHE A 498 1.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PHE A 122 CB PHE A 122 CG -0.114 REMARK 500 PHE A 151 CB PHE A 151 CG -0.103 REMARK 500 ARG A 193 CG ARG A 193 CD -0.164 REMARK 500 PHE A 471 CB PHE A 471 CG -0.107 REMARK 500 VAL A 542 C GLU A 543 N 0.207 REMARK 500 GLU A 543 C VAL A 544 N 0.195 REMARK 500 PHE A 577 CB PHE A 577 CG -0.103 REMARK 500 TRP B 152 CB TRP B 152 CG -0.125 REMARK 500 SER B 187 CB SER B 187 OG -0.086 REMARK 500 TYR B 213 CB TYR B 213 CG -0.095 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 52 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 91 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG A 101 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 TYR A 116 CB - CG - CD2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ARG A 164 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 201 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 VAL A 542 O - C - N ANGL. DEV. = -9.6 DEGREES REMARK 500 ARG A 568 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 568 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 ARG B 292 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 55 -58.76 74.85 REMARK 500 ALA A 171 71.68 -150.43 REMARK 500 SER A 214 -179.48 -67.61 REMARK 500 GLU A 276 129.29 78.68 REMARK 500 ASP A 330 78.08 -161.74 REMARK 500 GLU A 408 -44.82 -131.29 REMARK 500 ALA A 441 -58.00 71.75 REMARK 500 SER A 477 117.13 -168.33 REMARK 500 GLN A 497 -16.33 -159.52 REMARK 500 HIS A 507 -63.97 -132.48 REMARK 500 CYS A 518 -73.71 -122.38 REMARK 500 ASP A 531 108.63 68.55 REMARK 500 TRP B 54 79.53 -101.64 REMARK 500 PRO B 68 40.37 -93.86 REMARK 500 LEU B 86 144.51 -170.06 REMARK 500 THR B 259 41.49 35.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-27078 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURES AND COMPUTATIONAL ANALYSIS FOR ENHANCED POTENCY REMARK 900 IN MTA-SYNERGIC INHIBITION OF HUMAN PROTEIN ARGININE REMARK 900 METHYLTRANSFERASE 5 DBREF 8CYI A 1 637 UNP O14744 ANM5_HUMAN 1 637 DBREF 8CYI B 21 329 UNP Q9BQA1 MEP50_HUMAN 21 329 SEQRES 1 A 637 MET ALA ALA MET ALA VAL GLY GLY ALA GLY GLY SER ARG SEQRES 2 A 637 VAL SER SER GLY ARG ASP LEU ASN CYS VAL PRO GLU ILE SEQRES 3 A 637 ALA ASP THR LEU GLY ALA VAL ALA LYS GLN GLY PHE ASP SEQRES 4 A 637 PHE LEU CYS MET PRO VAL PHE HIS PRO ARG PHE LYS ARG SEQRES 5 A 637 GLU PHE ILE GLN GLU PRO ALA LYS ASN ARG PRO GLY PRO SEQRES 6 A 637 GLN THR ARG SER ASP LEU LEU LEU SER GLY ARG ASP TRP SEQRES 7 A 637 ASN THR LEU ILE VAL GLY LYS LEU SER PRO TRP ILE ARG SEQRES 8 A 637 PRO ASP SER LYS VAL GLU LYS ILE ARG ARG ASN SER GLU SEQRES 9 A 637 ALA ALA MET LEU GLN GLU LEU ASN PHE GLY ALA TYR LEU SEQRES 10 A 637 GLY LEU PRO ALA PHE LEU LEU PRO LEU ASN GLN GLU ASP SEQRES 11 A 637 ASN THR ASN LEU ALA ARG VAL LEU THR ASN HIS ILE HIS SEQRES 12 A 637 THR GLY HIS HIS SER SER MET PHE TRP MET ARG VAL PRO SEQRES 13 A 637 LEU VAL ALA PRO GLU ASP LEU ARG ASP ASP ILE ILE GLU SEQRES 14 A 637 ASN ALA PRO THR THR HIS THR GLU GLU TYR SER GLY GLU SEQRES 15 A 637 GLU LYS THR TRP MET TRP TRP HIS ASN PHE ARG THR LEU SEQRES 16 A 637 CYS ASP TYR SER LYS ARG ILE ALA VAL ALA LEU GLU ILE SEQRES 17 A 637 GLY ALA ASP LEU PRO SER ASN HIS VAL ILE ASP ARG TRP SEQRES 18 A 637 LEU GLY GLU PRO ILE LYS ALA ALA ILE LEU PRO THR SER SEQRES 19 A 637 ILE PHE LEU THR ASN LYS LYS GLY PHE PRO VAL LEU SER SEQRES 20 A 637 LYS MET HIS GLN ARG LEU ILE PHE ARG LEU LEU LYS LEU SEQRES 21 A 637 GLU VAL GLN PHE ILE ILE THR GLY THR ASN HIS HIS SER SEQRES 22 A 637 GLU LYS GLU PHE CYS SER TYR LEU GLN TYR LEU GLU TYR SEQRES 23 A 637 LEU SER GLN ASN ARG PRO PRO PRO ASN ALA TYR GLU LEU SEQRES 24 A 637 PHE ALA LYS GLY TYR GLU ASP TYR LEU GLN SER PRO LEU SEQRES 25 A 637 GLN PRO LEU MET ASP ASN LEU GLU SER GLN THR TYR GLU SEQRES 26 A 637 VAL PHE GLU LYS ASP PRO ILE LYS TYR SER GLN TYR GLN SEQRES 27 A 637 GLN ALA ILE TYR LYS CYS LEU LEU ASP ARG VAL PRO GLU SEQRES 28 A 637 GLU GLU LYS ASP THR ASN VAL GLN VAL LEU MET VAL LEU SEQRES 29 A 637 GLY ALA GLY ARG GLY PRO LEU VAL ASN ALA SER LEU ARG SEQRES 30 A 637 ALA ALA LYS GLN ALA ASP ARG ARG ILE LYS LEU TYR ALA SEQRES 31 A 637 VAL GLU LYS ASN PRO ASN ALA VAL VAL THR LEU GLU ASN SEQRES 32 A 637 TRP GLN PHE GLU GLU TRP GLY SER GLN VAL THR VAL VAL SEQRES 33 A 637 SER SER ASP MET ARG GLU TRP VAL ALA PRO GLU LYS ALA SEQRES 34 A 637 ASP ILE ILE VAL SER GLU LEU LEU GLY SER PHE ALA ASP SEQRES 35 A 637 ASN GLU LEU SER PRO GLU CYS LEU ASP GLY ALA GLN HIS SEQRES 36 A 637 PHE LEU LYS ASP ASP GLY VAL SER ILE PRO GLY GLU TYR SEQRES 37 A 637 THR SER PHE LEU ALA PRO ILE SER SER SER LYS LEU TYR SEQRES 38 A 637 ASN GLU VAL ARG ALA CYS ARG GLU LYS ASP ARG ASP PRO SEQRES 39 A 637 GLU ALA GLN PHE GLU MET PRO TYR VAL VAL ARG LEU HIS SEQRES 40 A 637 ASN PHE HIS GLN LEU SER ALA PRO GLN PRO CYS PHE THR SEQRES 41 A 637 PHE SER HIS PRO ASN ARG ASP PRO MET ILE ASP ASN ASN SEQRES 42 A 637 ARG TYR CYS THR LEU GLU PHE PRO VAL GLU VAL ASN THR SEQRES 43 A 637 VAL LEU HIS GLY PHE ALA GLY TYR PHE GLU THR VAL LEU SEQRES 44 A 637 TYR GLN ASP ILE THR LEU SER ILE ARG PRO GLU THR HIS SEQRES 45 A 637 SER PRO GLY MET PHE SER TRP PHE PRO ILE LEU PHE PRO SEQRES 46 A 637 ILE LYS GLN PRO ILE THR VAL ARG GLU GLY GLN THR ILE SEQRES 47 A 637 CYS VAL ARG PHE TRP ARG CYS SER ASN SER LYS LYS VAL SEQRES 48 A 637 TRP TYR GLU TRP ALA VAL THR ALA PRO VAL CYS SER ALA SEQRES 49 A 637 ILE HIS ASN PRO THR GLY ARG SER TYR THR ILE GLY LEU SEQRES 1 B 309 PRO ASN ALA PRO ALA CYS MET GLU ARG GLN LEU GLU ALA SEQRES 2 B 309 ALA ARG TYR ARG SER ASP GLY ALA LEU LEU LEU GLY ALA SEQRES 3 B 309 SER SER LEU SER GLY ARG CYS TRP ALA GLY SER LEU TRP SEQRES 4 B 309 LEU PHE LYS ASP PRO CYS ALA ALA PRO ASN GLU GLY PHE SEQRES 5 B 309 CYS SER ALA GLY VAL GLN THR GLU ALA GLY VAL ALA ASP SEQRES 6 B 309 LEU THR TRP VAL GLY GLU ARG GLY ILE LEU VAL ALA SER SEQRES 7 B 309 ASP SER GLY ALA VAL GLU LEU TRP GLU LEU ASP GLU ASN SEQRES 8 B 309 GLU THR LEU ILE VAL SER LYS PHE CYS LYS TYR GLU HIS SEQRES 9 B 309 ASP ASP ILE VAL SER THR VAL SER VAL LEU SER SER GLY SEQRES 10 B 309 THR GLN ALA VAL SER GLY SER LYS ASP ILE CYS ILE LYS SEQRES 11 B 309 VAL TRP ASP LEU ALA GLN GLN VAL VAL LEU SER SER TYR SEQRES 12 B 309 ARG ALA HIS ALA ALA GLN VAL THR CYS VAL ALA ALA SER SEQRES 13 B 309 PRO HIS LYS ASP SER VAL PHE LEU SER CYS SER GLU ASP SEQRES 14 B 309 ASN ARG ILE LEU LEU TRP ASP THR ARG CYS PRO LYS PRO SEQRES 15 B 309 ALA SER GLN ILE GLY CYS SER ALA PRO GLY TYR LEU PRO SEQRES 16 B 309 THR SER LEU ALA TRP HIS PRO GLN GLN SER GLU VAL PHE SEQRES 17 B 309 VAL PHE GLY ASP GLU ASN GLY THR VAL SER LEU VAL ASP SEQRES 18 B 309 THR LYS SER THR SER CYS VAL LEU SER SER ALA VAL HIS SEQRES 19 B 309 SER GLN CYS VAL THR GLY LEU VAL PHE SER PRO HIS SER SEQRES 20 B 309 VAL PRO PHE LEU ALA SER LEU SER GLU ASP CYS SER LEU SEQRES 21 B 309 ALA VAL LEU ASP SER SER LEU SER GLU LEU PHE ARG SER SEQRES 22 B 309 GLN ALA HIS ARG ASP PHE VAL ARG ASP ALA THR TRP SER SEQRES 23 B 309 PRO LEU ASN HIS SER LEU LEU THR THR VAL GLY TRP ASP SEQRES 24 B 309 HIS GLN VAL VAL HIS HIS VAL VAL PRO THR HET P2R A 801 57 HET MTA A 802 35 HETNAM P2R N-[(2-AMINOQUINOLIN-7-YL)METHYL]-9-(2-HYDROXYETHYL)-2, HETNAM 2 P2R 3,4,9-TETRAHYDRO-1H-CARBAZOLE-6-CARBOXAMIDE HETNAM MTA 5'-DEOXY-5'-METHYLTHIOADENOSINE FORMUL 3 P2R C25 H26 N4 O2 FORMUL 4 MTA C11 H15 N5 O3 S HELIX 1 AA1 GLU A 25 GLN A 36 1 12 HELIX 2 AA2 PRO A 58 ARG A 62 5 5 HELIX 3 AA3 SER A 69 LEU A 73 5 5 HELIX 4 AA4 SER A 74 LEU A 81 1 8 HELIX 5 AA5 VAL A 96 GLY A 118 1 23 HELIX 6 AA6 ASN A 131 HIS A 143 1 13 HELIX 7 AA7 ALA A 159 ARG A 164 5 6 HELIX 8 AA8 GLU A 178 GLU A 182 5 5 HELIX 9 AA9 GLU A 183 CYS A 196 1 14 HELIX 10 AB1 ILE A 218 LEU A 222 5 5 HELIX 11 AB2 SER A 234 PHE A 236 5 3 HELIX 12 AB3 SER A 247 LYS A 259 1 13 HELIX 13 AB4 HIS A 272 PHE A 277 5 6 HELIX 14 AB5 CYS A 278 GLN A 289 1 12 HELIX 15 AB6 ASN A 295 ALA A 301 1 7 HELIX 16 AB7 GLU A 320 GLU A 328 1 9 HELIX 17 AB8 ASP A 330 ASP A 347 1 18 HELIX 18 AB9 PRO A 350 THR A 356 5 7 HELIX 19 AC1 GLY A 369 ASP A 383 1 15 HELIX 20 AC2 ASN A 394 GLU A 408 1 15 HELIX 21 AC3 TRP A 409 SER A 411 5 3 HELIX 22 AC4 LEU A 445 ALA A 453 1 9 HELIX 23 AC5 SER A 477 ALA A 486 1 10 HELIX 24 AC6 ARG A 568 HIS A 572 5 5 HELIX 25 AC7 ASN A 627 ARG A 631 5 5 HELIX 26 AC8 ASP B 63 ALA B 67 5 5 HELIX 27 AC9 ASN B 69 CYS B 73 5 5 SHEET 1 AA1 9 SER A 16 ASP A 19 0 SHEET 2 AA1 9 PHE A 40 CYS A 42 1 O CYS A 42 N ARG A 18 SHEET 3 AA1 9 ILE A 82 LYS A 85 1 O VAL A 83 N LEU A 41 SHEET 4 AA1 9 ALA A 121 PRO A 125 1 O ALA A 121 N GLY A 84 SHEET 5 AA1 9 MET A 150 PRO A 156 1 O ARG A 154 N LEU A 124 SHEET 6 AA1 9 ILE A 202 GLU A 207 1 O ALA A 205 N MET A 153 SHEET 7 AA1 9 ILE A 226 PRO A 232 1 O ILE A 230 N LEU A 206 SHEET 8 AA1 9 GLN A 263 THR A 267 1 O ILE A 265 N ALA A 229 SHEET 9 AA1 9 SER A 16 ASP A 19 1 N GLY A 17 O ILE A 266 SHEET 1 AA2 2 LEU A 237 THR A 238 0 SHEET 2 AA2 2 PRO A 244 VAL A 245 -1 O VAL A 245 N LEU A 237 SHEET 1 AA3 6 LEU A 308 GLN A 309 0 SHEET 2 AA3 6 TYR A 502 VAL A 504 -1 O VAL A 503 N GLN A 309 SHEET 3 AA3 6 ILE A 582 VAL A 592 -1 O LEU A 583 N TYR A 502 SHEET 4 AA3 6 THR A 546 TYR A 560 -1 N PHE A 551 O PHE A 584 SHEET 5 AA3 6 GLU A 467 SER A 476 -1 N ILE A 475 O GLY A 550 SHEET 6 AA3 6 GLN A 516 SER A 522 -1 O CYS A 518 N SER A 470 SHEET 1 AA4 4 HIS A 510 GLN A 511 0 SHEET 2 AA4 4 GLU A 467 SER A 476 -1 N SER A 476 O HIS A 510 SHEET 3 AA4 4 THR A 546 TYR A 560 -1 O GLY A 550 N ILE A 475 SHEET 4 AA4 4 ILE A 563 SER A 566 -1 O LEU A 565 N THR A 557 SHEET 1 AA5 5 VAL A 413 SER A 417 0 SHEET 2 AA5 5 ARG A 385 GLU A 392 1 N ALA A 390 O THR A 414 SHEET 3 AA5 5 VAL A 358 LEU A 364 1 N VAL A 363 O TYR A 389 SHEET 4 AA5 5 ALA A 429 SER A 434 1 O VAL A 433 N MET A 362 SHEET 5 AA5 5 LEU A 457 ILE A 464 1 O LYS A 458 N ALA A 429 SHEET 1 AA6 4 ARG A 534 PRO A 541 0 SHEET 2 AA6 4 THR A 597 SER A 606 -1 O ILE A 598 N PHE A 540 SHEET 3 AA6 4 LYS A 610 ALA A 619 -1 O ALA A 616 N ARG A 601 SHEET 4 AA6 4 ILE A 635 GLY A 636 -1 O ILE A 635 N VAL A 611 SHEET 1 AA7 4 GLN B 30 TYR B 36 0 SHEET 2 AA7 4 LEU B 42 SER B 47 -1 O LEU B 43 N ARG B 35 SHEET 3 AA7 4 GLY B 56 PHE B 61 -1 O TRP B 59 N LEU B 44 SHEET 4 AA7 4 ALA B 75 GLN B 78 -1 O ALA B 75 N LEU B 60 SHEET 1 AA8 4 VAL B 83 VAL B 89 0 SHEET 2 AA8 4 GLY B 93 SER B 98 -1 O ALA B 97 N ALA B 84 SHEET 3 AA8 4 ALA B 102 LEU B 108 -1 O TRP B 106 N ILE B 94 SHEET 4 AA8 4 ILE B 115 TYR B 122 -1 O LYS B 118 N LEU B 105 SHEET 1 AA9 4 VAL B 128 VAL B 133 0 SHEET 2 AA9 4 GLN B 139 SER B 144 -1 O VAL B 141 N SER B 132 SHEET 3 AA9 4 ILE B 149 ASP B 153 -1 O TRP B 152 N ALA B 140 SHEET 4 AA9 4 VAL B 158 TYR B 163 -1 O LEU B 160 N VAL B 151 SHEET 1 AB1 4 VAL B 170 ALA B 175 0 SHEET 2 AB1 4 VAL B 182 SER B 187 -1 O LEU B 184 N ALA B 174 SHEET 3 AB1 4 ILE B 192 ASP B 196 -1 O TRP B 195 N PHE B 183 SHEET 4 AB1 4 ALA B 203 GLN B 205 -1 O SER B 204 N LEU B 194 SHEET 1 AB2 4 PRO B 215 TRP B 220 0 SHEET 2 AB2 4 VAL B 227 ASP B 232 -1 O GLY B 231 N THR B 216 SHEET 3 AB2 4 THR B 236 ASP B 241 -1 O SER B 238 N PHE B 230 SHEET 4 AB2 4 LEU B 249 ALA B 252 -1 O LEU B 249 N LEU B 239 SHEET 1 AB3 4 LEU B 261 PHE B 263 0 SHEET 2 AB3 4 LEU B 271 SER B 273 -1 O ALA B 272 N VAL B 262 SHEET 3 AB3 4 LEU B 280 LEU B 283 -1 O LEU B 283 N LEU B 271 SHEET 4 AB3 4 GLU B 289 SER B 293 -1 O LEU B 290 N VAL B 282 SHEET 1 AB4 3 VAL B 300 TRP B 305 0 SHEET 2 AB4 3 LEU B 312 GLY B 317 -1 O THR B 314 N THR B 304 SHEET 3 AB4 3 VAL B 322 VAL B 326 -1 O HIS B 325 N LEU B 313 CISPEP 1 GLU A 57 PRO A 58 0 -5.07 CISPEP 2 ILE A 464 PRO A 465 0 3.48 CISPEP 3 HIS A 523 PRO A 524 0 -5.55 CISPEP 4 ALA A 619 PRO A 620 0 0.96 CISPEP 5 ALA B 67 PRO B 68 0 -4.17 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000